US Broker Ratings

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Analyzing a 33% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotechnology sector with a significant market cap of $11.76 billion. This Pennsylvania-based company is at the forefront of developing therapeutics for..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Strategic Hold in the Biotech Space with Steady Potential

Soleno Therapeutics, Inc. (SLNO) is making waves in the biotechnology industry as it focuses on developing treatments for rare diseases, with its lead product candidate being VYKAT XR, targeting Prader-Willi..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 24.88% Potential Upside in the Biotech Sector

Roivant Sciences Ltd. (ROIV), a UK-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a strong focus on innovative medicines and technologies. As individual investors seek opportunities..

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with 36% Potential Upside

In the dynamic world of healthcare and medical instruments, Stevanato Group S.p.A. (NYSE: STVN) stands out as a formidable player. With a market capitalization of $4.98 billion, this Italian company..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Position

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector’s medical care facilities industry, presents an intriguing case for investors seeking exposure to the niche market of kidney dialysis services...

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings Signal Promising Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company, is rapidly gaining attention in the healthcare sector with its innovative genetic medicines. With a market capitalization of $9.01 billion, Krystal..

Viatris Inc. (VTRS) Stock Analysis: Exploring the Healthcare Giant’s Valuation and Dividend Yield

Viatris Inc. (VTRS), a substantial player in the healthcare sector, has piqued the interest of investors with its expansive reach and diverse product portfolio. With a market capitalization of $20..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: High Growth Potential with a 52.61% Upside

iRhythm Holdings, Inc. (NASDAQ: IRTC), a leader in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive growth trajectory and significant upside potential. With a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Gem with 46.76% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a compelling player in the biotechnology sector, focusing on pioneering solutions for rare neuroendocrine diseases. With a market cap of $6.45 billion, this Boston-based..

Biogen Inc. (BIIB) Stock Analysis: Potential 12% Upside Amid Strong Buy Ratings

Biogen Inc. (NASDAQ: BIIB), a leading player in the healthcare sector, has consistently been in the spotlight for its innovative contributions to the field of biotechnology. With a market capitalization..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth With a 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR), a key player in the healthcare technology sector, is making waves with its impressive revenue growth of 52.60%. This New York-based company, originally incorporated as..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 102% Potential Upside Amid Robust Revenue Growth

Investors with a keen eye on the biotechnology sector might find Insmed Incorporated (NASDAQ: INSM) an intriguing prospect, especially given its substantial potential upside of 102.12% based on the average..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with Growth Potential and Strategic Vision

Investors eyeing the biotechnology sector should take a closer look at Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a Dublin-based company making significant strides in the healthcare industry. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Is a 20.50% Potential Upside Worth the Investment?

Inspire Medical Systems, Inc. (INSP), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its innovative solutions for obstructive sleep apnea (OSA). Despite..

Labcorp Holdings Inc. (LH) Stock Analysis: A 22% Potential Upside with Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, specifically within diagnostics and research, presents an intriguing investment opportunity for those eyeing the medical diagnostics landscape. As..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech with 35.91% Potential Upside and Groundbreaking Innovations

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is making waves with its focus on developing groundbreaking muscle activators and inhibitors. Based in South San Francisco, California,..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 42% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, specifically within the medical care facilities industry, as a robust player offering comprehensive home and alternate site infusion..

Masimo Corporation (MASI) Stock Analysis: Navigating the Healthcare Sector with Steady Growth and Innovation

Masimo Corporation (MASI), a prominent player in the healthcare sector, is carving out a significant niche in the medical devices industry. With a market capitalization of $9.34 billion, Masimo is..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring the 91% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) presents a compelling investment opportunity for those willing to navigate the inherently volatile landscape of biotechnology. With a market capitalization of $202.78 million, this San..

Charles River Laboratories (CRL) Stock Analysis: Harnessing a 17.67% Potential Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With its broad range of services aimed at drug..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds